Balanced news tone
News Sentiment
DCOY sentiment intelligence
Decoy Therapeutics Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
85/100 classification confidence.
directly relevant articles
high-authority source matches
-5.1% over one week, -7.6% over four weeks, trend inactive, and below fair value.
Decoy Therapeutics (DCOY) price target increased by 1,100.00% to 30.60
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
DCOY Stock Price and Chart — NASDAQ:DCOY
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jan 2026 15:45
- Source
- TradingView
Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jan 2026 08:00
- Source
- Market source